Pre-earnings options volume in Ambrx Biopharma is normal with puts leading calls 13:1. Implied volatility suggests the market is anticipating a move near 9.7%, or 0c, after results are released. Median move over the past eight quarters is 2.2%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AMAM:
- Cantor biotech/biopharma analysts hold analyst/industry conference call
- Fly Insider: Ambrx, Intuitive Surgical among week’s notable insider trades
- Largest borrow rate increases among liquid names
- Cantor biotech/biopharma analysts hold an analyst/industry conference call
- Ambrx Biopharma price target raised to $33 from $29 at RBC Capital
